TRADE NEWS: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics
12 February 2016 - 3:00AM
Business Wire
Agilent Technologies Inc. (NYSE:A) today announced a program
that gives biologists conducting functional genomics research early
access to a potential new resource: custom CRISPR guideRNA
libraries using Agilent’s high-quality oligo library synthesis
platform.
Agilent announced the early access program at a technology
conference—Advances in Genome Biology and Technology (AGBT)—which
continues through Friday in Orlando, Florida.
The custom SureGuide gRNA libraries will complement Agilent’s
SureGuide Cas9 nuclease kit when that kit is available for
commercial release. Both will be part of an integrated solution for
research involving clustered regularly interspaced short
palindromic repeats (known as CRISPR systems) and associated
genes.
Researchers are excited about CRISPR-Cas9 gene-editing
technology because it enables scientists doing large-scale,
functional genomics screens to investigate the role of genetic
mutations in human disease. With CRISPR libraries, researchers have
access to the first system that can fully remove the function of
genes at the DNA level, compared with other tools like RNA
interference that suppress gene expression at the RNA level.
“We are pleased to provide researchers with early access to
custom SureGuide gRNA for evaluation,” said Alessandro Borsatti,
the head of product marketing for Agilent’s Diagnostics and
Genomics Group. “This program will accelerate the ability of
researchers to identify critical sequences responsible for a gene’s
functional properties and enable them to perform targeted genome
editing with unprecedented ease.”
Scientists who would like to take part in the early access
program and provide feedback to Agilent can sign up at
www.agilent.com/genomics/CRISPREA.
At AGBT today, Israel Steinfeld, a scientist from Agilent Labs,
will deliver a presentation titled “Improved Methods and Analysis
Tools for Efficient CRISPR/Cas Genome Editing.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE:A), a global leader in life
sciences, diagnostics and applied chemical markets, is the premier
laboratory partner for a better world. Agilent works with customers
in more than 100 countries, providing instruments, software,
services and consumables for the entire laboratory workflow. The
company generated revenue of $4.04 billion in fiscal 2015 and
employs about 12,000 people worldwide. Information about Agilent is
available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and
executive news is available at www.agilent.com/go/news.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160211005289/en/
Agilent Technologies Inc.Victoria Wadsworth-Hansen, +1
408-553-2005victoria.wadsworth-hansen@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2024 to May 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From May 2023 to May 2024